Angiopoietin-like Protein 7/ANGPTL7 Antibody (121408) [Alexa Fluor® 750]

• Reactivity: Hu
• Applications: WB
• Clone: 121408
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Alexa Fluor 750

Angiopoietin-like Protein 7/ANGPTL7 Antibody (121408) [Alexa Fluor® 750] Summary

• Immunogen: E. coli-derived recombinant human Angiopoietin-like Protein 7/ANGPTL7
  Lys28-Pro346
  Accession # O43827
• Specificity: Detects human Angiopoietin-like Protein 7/ANGPTL7 in direct ELISAs and Western blots. In Western blots, less than 3% cross-reactivity with recombinant human Angiopoietin-1 is observed.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Angiopoietin-like Protein 7/ANGPTL7 Antibody (121408) [Alexa Fluor® 750]

• angiopoietin-like 7
• Angiopoietin-like factor
• Angiopoietin-like Protein 7
• angiopoietin-related protein 7
• ANGPTL7
• AngX
• CDT6
• CDT6angiopoietin-like factor (CDT6)
• Cornea-derived transcript 6 protein
• dJ647M16.1
• RP4-647M16.2

Background

Angiopoietin-like Protein 7 (ANGPTL7), also known as cornea-derived transcript 6 (CDT6), is a secreted 45 kDa protein that contains a coiled-coil domain (aa 30‑110) and a fibrinogen-like domain (aa 113‑334). ANGPTL7 is expressed in the stromal layer of the cornea, and it forms disulfide-linked homotetramers. It contributes to corneal morphogenesis by suppressing angiogenesis and promoting the deposition of extracellular matrix components. ANGPTL7 is up-regulated in glaucoma and accumulates in the aqueous humor. Mature mouse ANGPTL7 shares 88% and 98% sequence identity with human and rat ANGPTL7.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.